Cite
[Administration of monoclonal antibodies to B-lymphocytes (rituximab) in rheumatoid arthritis in Russia].
MLA
Nasonov, E. L., et al. “[Administration of Monoclonal Antibodies to B-Lymphocytes (Rituximab) in Rheumatoid Arthritis in Russia].” Terapevticheskii Arkhiv, vol. 80, no. 8, 2008, pp. 57–62. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18807543&authtype=sso&custid=ns315887.
APA
Nasonov, E. L., Lukina, G. V., Sigidin, I. A., Bazevich, L. A., Zlobina, T. I., Kamalova, R. G., Kniazeva, L. A., Mazurov, V. I., Men’shikova, L. V., Sizikov, A. E., Smirnova, E. A., Fofonova, N. A., Shabalina, T. V., Shkil’, N. V., & Iakushin, S. S. (2008). [Administration of monoclonal antibodies to B-lymphocytes (rituximab) in rheumatoid arthritis in Russia]. Terapevticheskii Arkhiv, 80(8), 57–62.
Chicago
Nasonov, E L, G V Lukina, Ia A Sigidin, L A Bazevich, T I Zlobina, R G Kamalova, L A Kniazeva, et al. 2008. “[Administration of Monoclonal Antibodies to B-Lymphocytes (Rituximab) in Rheumatoid Arthritis in Russia].” Terapevticheskii Arkhiv 80 (8): 57–62. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=18807543&authtype=sso&custid=ns315887.